弓形虫病

Desmonts G. Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Eng J Med. 1974;290:1110-1116.

• 摘要

Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143-1238.

• 全文
• 摘要

Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:e1-e34.

• 全文
• 摘要

McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006;42:1383-1394.

• 摘要

Roberts F, Kuo A, Jones L, et al. Ocular toxoplasmosis: clinical features, pathology, pathogenesis, animal models, and immune responses. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 4.

1.  Dubey JP. The life cycle of Toxoplasma gondii. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 1.

2.  Jones JL, Kruszon-Moran D, Rivera H, et al. Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90:1135-1139.

• 摘要

3.  Petersen E. Epidemiology, diagnostics, and chemotherapy. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 3.

4.  Eskild A, Oxman A, Magnus P, et al. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen. 1996;3:188-194.

• 摘要

5.  Health Protection Agency. Toxoplasmosis. http://www.hpa.org.uk (last accessed 22 June 2016).

• 全文

6.  Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004 Jun 12;363(9425):1965-76.

• 摘要

7.  Desmonts G. Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Eng J Med. 1974;290:1110-1116.

• 摘要

8.  Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet. 1999;353:1829-1833.

• 摘要

9.  Howe D, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995;172:1561-1566.

• 摘要

10.  Zhou P, Zhang H, Lin RQ, et al. Genetic characterization of Toxoplasma gondii isolates from China. Parasitol Int. 2009;58:193-195.

• 摘要

11.  Ferreira Ade M, Vitor RW, Gazzinelli RT, et al. Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP. Infect Genet Evol. 2006;6:22-31.

• 摘要

12.  Boughattas S, Ben-Abdallah R, Siala E, et al. Direct genotypic characterization of Toxoplasma gondii strains associated with congenital toxoplasmosis in Tunisia (North Africa). Am J Trop Med Hyg. 2010;82:1041-1046.

• 摘要

13.  Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49:878-884.

• 摘要

14.  Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 1998;11:267-299.

• 全文
• 摘要

15.  Wilson CB, Remington JS, Stagno S, et al. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980;66:767-774.

• 摘要

16.  Campbell AL, Goldberg CL, Magid MS, et al. First case of toxoplasmosis following small bowel transplantation and systematic review of tissue-invasive toxoplasmosis following noncardiac solid organ transplantation. Transplantation. 2006;81:408-417.

• 摘要

17.  Goldszmid RS, Bafica A, Jankovic D, et al. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J Exp Med. 2007;204:2591-2602.

• 全文
• 摘要

18.  Liu CH, Fan YT, Dias A, et al. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol. 2006;177:31-35.

• 全文
• 摘要

19.  Perona-Wright G, Mohrs K, Szaba FM, et al. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe. 2009;6:503-512.

• 全文
• 摘要

20.  Hunter CA, Lieberman LA, Mason N, et al. Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma. Immunol Res. 2003;27:331-340.

• 摘要

21.  Adams LB, Hibbs JB Jr, Taintor RR, et al. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990;144:2725-2729.

• 摘要

22.  Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2016. http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf (last accessed 1 July 2016)

• 全文

23.  Zufferey J, Sugar A, Rudaz P, et al. Prevalence of latent toxoplasmosis and serologic diagnosis of active infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis. 1993;12:591-595.

• 摘要

24.  Zangerle R, Allerberger F, Pohl P, et al. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol. 1991;180:59-66.

• 摘要

25.  Parasitic infections. Am J Transplant. 2004;4(suppl 10):142-155.

• 全文
• 摘要

26.  Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143-1238.

• 全文
• 摘要

27.  Kim K. Toxoplasmosis. In: Conn's current therapy, Rakel RE, ed. Philadelphia, PA: WB Saunders; 2000:151-157.

28.  Pfaff AW, Liesenfeld O, Candolfi E. Congenital toxoplasmosis. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 5.

29.  Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Infectious diseases of the fetus and newborn infant. JS Remington, JO Klein, eds. Philadelphia, PA: WB Saunders; 1995:chapter 5.

30.  Chapey E, Wallon M, Debize G, et al. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J Clin Microbiol. 2010;48:41-45.

• 全文
• 摘要

31.  Hoffmann C, Ernst M, Meyer P, et al. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses. Clin Microbiol Infect. 2007;13:510-515.

• 全文
• 摘要

32.  Palanisamy M, Madhavan B, Balasundaram MB, et al. Outbreak of ocular toxoplasmosis in Coinbatore, India. Indian J Ophthalmol. 2006;54:129-131.

• 全文
• 摘要

33.  Boyer KM, Remington JS, McLeod R. Toxoplasmosis. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD, Demmler GJ, et al, eds. Philadelphia, PA: Saunders; 2004:chapter 222.

34.  Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol. 2004;42:941-945.

• 全文
• 摘要

35.  Cinque P, Scarpellini P, Vago L, et al. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS. 1997;11:1-17.

• 摘要

36.  Robert-Gangneux F, Sterkers Y, Yera H, et al. Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study. J Clin Microbiol. 2015;53:1677-1684.

• 摘要

37.  Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:e1-e34.

• 全文
• 摘要

38.  National Institute for Health and Care Excellence. Antenatal care: routine care for the healthy pregnant woman. March 2008. http://guidance.nice.org.uk (last accessed 22 June 2016).

• 全文

39.  ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. (Replaces educational bulletin number 177, February 1993). American College of Obstetrics and Gynecologists. Int J Gynaecol Obstet. 2002;76:95-107.

• 摘要

40.  Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med. 1994;330:1858-1863.

• 摘要

41.  Siberry GK, Abzug MJ, Nachman S, et al. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J. 2013;32 (Suppl 2):i-KK4.

• 全文
• 摘要

42.  SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiebaut R, Leproust S, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007;369:115-122.

• 摘要

43.  Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 1988;318:271-275.

• 摘要

44.  Brown ED, Chau JK, Atashband S, et al. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2009;73:707-711.

• 摘要

45.  McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006;42:1383-1394.

• 摘要

46.  Roberts F, Kuo A, Jones L, et al. Ocular toxoplasmosis: clinical features, pathology, pathogenesis, animal models, and immune responses. In: Ajioka JW, Soldati D, eds. Toxoplasma molecular and cellular biology. Norfolk, UK: Horizon Bioscience; 2007:chapter 4.

47.  Gilbert RE, See SE, Jones LV, et al. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database Syst Rev. 2002;(1):CD002218.

• 全文
• 摘要

48.  Stanford MR, See SE, Jones LV, et al. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology. 2003;110:926-932.

• 摘要

49.  Jasper S, Vedula SS, John SS, et al. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane database Syst Rev. 2013;(4):CD007417.

• 全文
• 摘要

50.  Silveira C, Belfort R, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134:41-46.

• 摘要

51.  Kim SJ, Scott IU, Brown GC, et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013;120:371-378.

• 摘要

52.  Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005;112:1876-1882.

• 摘要

53.  Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina. 2007;27:952-957.

• 摘要

54.  Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002;134:34-40.

• 摘要

55.  Baharivand N, Mahdavifard A, Fouladi RF, et al. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial. Int Ophthalmol. 2013;33:39-46.

• 摘要

56.  Felix JP, Lira RP, Zacchia RS, et al. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Am J Ophthalmol. 2014;157:762-766;e1.

• 摘要

57.  Wallon M, Peyron F, Cornu C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56:1223-1231.

• 摘要